ReShape Lifesciences Inc. (RSLS) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    ReShape Lifesciences Inc.

    NASDAQ: RSLS · Real-Time Price · USD
    3.92
    0.72 (22.50%)
    At close: Aug 14, 2025, 3:59 PM

    ReShape Lifesciences Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 8.01M 8.68M 11.24M 13.6M
    Cost of Revenue
    		 2.95M 3.13M 4.44M 5.25M
    Gross Profit
    		 5.06M 5.55M 6.8M 8.35M
    Operating Income
    		 -6.67M -14.64M -27.08M -24.93M
    Interest Income
    		 14K 26K n/a n/a
    Pretax Income
    		 -7.09M -11.34M -46.59M -63.42M
    Net Income
    		 -7.13M -11.39M -46.21M -63.15M
    Selling & General & Admin
    		 9.92M 17.87M 31.34M 33.58M
    Research & Development
    		 1.8M 2.31M 2.54M 2.52M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 11.72M 20.19M 33.88M 36.1M
    Interest Expense
    		 n/a n/a 113K 832K
    Selling & Marketing Expenses
    		 2.99M 7.55M 14.09M 8.89M
    Cost & Expenses
    		 15.73M 23.32M 57.59M 71.48M
    Income Tax Expense
    		 39K 52K -380K -274K
    Shares Outstanding (Basic)
    		 20.62K 4.11K 292.68 150.70
    Shares Outstanding (Diluted)
    		 20.62K 4.11K 292.68 150.70
    EPS (Basic)
    		 -345.74 -2.77K -157.9K -419K
    EPS (Diluted)
    		 -345.74 -2.77K -157.9K -419K
    EBITDA
    		 -6.67M -14.48M -24.93M -60.62M
    EBIT
    		 -6.67M -14.64M -27.08M -62.59M
    Depreciation & Amortization
    		 22K 154K 2.15M 1.97M

    Add to Watchlist